First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease(534 views) Nappi C, Altiero M, Imbriaco M, Nicolai E, Giudice CA, Aiello M, Diomiaiuti CT, Pisani A, Spinelli L, Cuocolo A
Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy
Department of Public Health, University Federico II, Naples, Italy
IRCCS SDN, Naples, Italy
References: Desnick, R.J., Ioannou, Y.A., Eng, C.M., α-Galactosidase A deficiency: Fabry disease (2001) The metabolic and molecular bases of inherited disease, pp. 3733-3774. , Scriver CR, Beaudet AL, Sly WS, Valle D, (eds), McGraw Hill, New York
Linhart, A., Kampmann, C., Zamorano, J.L., Sunder-Plassmann, G., Beck, M., Mehta, A., Elliott, P.M., European FOS investigators, Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey (2007) Eur Heart J, 28, pp. 1228-1235. , PID: 17483538
Wilcox, W.R., Oliveira, J.P., Hopkin, R.J., Ortiz, A., Banikazemi, M., Feldt-Rasmussen, U., Fabry registry. Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry (2008) Mol Genet Metab, 93, pp. 112-128. , COI: 1:CAS:528:DC%2BD1cXit1Sgsr0%3D, PID: 18037317
Schiffmann, R., Warnock, D.G., Banikazemi, M., Bultas, J., Linthorst, G.E., Packman, S., Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy (2009) Nephrol Dial Transplant, 24, pp. 2102-2111. , PID: 19218538
Moon, J.C., Sachdev, B., Elkington, A.G., McKenna, W.J., Mehta, A., Pennell, D.J., Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium (2003) Eur Heart J, 24, pp. 2151-2155. , PID: 14643276
Weidemann, F., Sanchez-Niño, M.D., Politei, J., Oliveira, J.P., Wanner, C., Warnock, D.G., Fibrosis: a key feature of Fabry disease with potential therapeutic implications (2013) Orphanet J Rare Dis, 8, p. 116. , PID: 23915644
Ratib, O., Nkoulou, R., Potential applications of PET/MR imaging in cardiology (2014) J Nucl Med, 55, pp. 40-46. , PID: 24762626
Rischpler, C., Nekolla, S.G., Dregely, I., Schwaiger, M., Hybrid PET/MR imaging of the heart: potential, initial experiences, and future prospects (2013) J Nucl Med, 54, pp. 402-415. , COI: 1:CAS:528:DC%2BC3sXltV2ksrk%3D, PID: 23404088
Mewton, N., Liu, C.Y., Croisille, P., Bluemke, D., Lima, J.A., Assessment of myocardial fibrosis with cardiovascular magnetic resonance (2011) J Am Coll Cardiol, 57, pp. 891-903. , PID: 21329834
Wu, K.C., Weiss, R.G., Thiemann, D.R., Kitagawa, K., Schmidt, A., Dalal, D., Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy (2008) J Am Coll Cardiol, 51, pp. 2414-2421. , PID: 18565399
Stirrat, J., White, J.A., The prognostic role of late gadolinium enhancement magnetic resonance imaging in patients with cardiomyopathy (2013) Can J Cardiol, 29, pp. 329-336. , PID: 23439019
O h-Ici, D., Ridgway, J.P., Kuehne, T., Berger, F., Plein, S., Sivananthan, M., Cardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: diagnostic accuracy of visual and semi-quantitative assessment (2012) J Cardiovasc Magn Reson, 14, p. 22. , PID: 22455461
vom Dahl, J., Altehoefer, C., Sheehan, F.H., Buechin, P., Schulz, G., Schwarz, E.R., Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease (1997) J Nucl Med, 38, pp. 742-748
James, O.G., Christensen, J.D., Wong, T.Z., Borges-Neto, S., Koweek, L.M., Utility of FDG PET/CT in inflammatory cardiovascular disease (2011) Radiographics, 31, pp. 1271-1286. , PID: 21918044
Dorbala, S., Di Carli, M.F., Delbeke, D., Abbara, S., DePuey, E.G., Dilsizian, V., SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0 (2013) J Nucl Med, 54, pp. 1485-1507. , PID: 23781013
Williams, G., Kolodny, G.M., Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet (2008) AJR Am J Roentgenol, 190, pp. 151-156. , PID: 18212199
Wykrzykowska, J., Lehman, S., Williams, G., Parker, J.A., Palmer, M.R., Varkey, S., Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation (2009) J Nucl Med, 50, pp. 563-568. , PID: 19289431
Nacif, M.S., Arai, A.E., Lima, J.A., Bluemke, D.A., Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines (2012) J Cardiovasc Magn Reson, 14, p. 18. , PID: 22376193
Ohira, H., Tsujino, I., Yoshinaga, K., 18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis (2011) Eur J Nucl Med Mol Imaging, 38, pp. 1773-1783. , COI: 1:CAS:528:DC%2BC3MXhtVOnsL7N, PID: 21559980
Tahara, N., Tahara, A., Nitta, Y., Kodama, N., Mizoguchi, M., Kaida, H., Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis (2010) JACC Cardiovasc Imaging, 3, pp. 1219-1228. , PID: 21163450
Feustel, A., Hahn, A., Schneider, C., Sieweke, N., Franzen, W., Gündüz, D., Continuous cardiac troponin I release in Fabry disease (2014) PLoS One, 9, p. 91757. , PID: 24626231
Brady, R.O., Schiffmann, R., Clinical features of and recent advances in therapy for Fabry disease (2000) JAMA, 284, pp. 2771-2775. , COI: 1:STN:280:DC%2BD3M%2Fms1Gntg%3D%3D, PID: 11105184
Pisani, A., Visciano, B., Roux, G.D., Sabbatini, M., Porto, C., Parenti, G., Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature (2012) Mol Genet Metab, 107, pp. 267-275. , COI: 1:CAS:528:DC%2BC38Xhtlamur3O, PID: 22963910
Weidemann, F., Niemann, M., Breunig, F., Herrmann, S., Beer, M., Störk, S., Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment (2009) Circulation, 119, pp. 524-529. , COI: 1:CAS:528:DC%2BD1MXpt1ektw%3D%3D, PID: 19153271
Shen, J.S., Meng, X.L., Moore, D.F., Quirk, J.M., Shayman, J.A., Schiffmann, R., Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells (2008) Mol Genet Metab, 95, pp. 163-168. , COI: 1:CAS:528:DC%2BD1cXht1Knt7zI, PID: 18707907
DeGraba, T., Azhar, S., Dignat-George, F., Brown, E., Boutière, B., Altarescu, G., Profile of endothelial and leukocyte activation in Fabry patients (2000) Ann Neurol, 47, pp. 229-233. , COI: 1:CAS:528:DC%2BD3cXhtV2mtrc%3D, PID: 10665494
Biancini, G.B., Vanzin, C.S., Rodrigues, D.B., Deon, M., Ribas, G.S., Barschak, A.G., Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy (1822) Biochim Biophys Acta, 2012, pp. 226-232
Niemann, M., Herrmann, S., Hu, K., Breunig, F., Strotmann, J., Beer, M., Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment (2011) JACC Cardiovasc Imaging, 4, pp. 592-601. , PID: 21679893
Inglese, E., Leva, L., Matheoud, R., Sacchetti, G., Secco, C., Gandolfo, P., Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT (2007) J Nucl Med, 48, pp. 1662-1669. , PID: 17873124
Imbriaco, M., Spinelli, L., Cuocolo, A., Maurea, S., Sica, G., Quarantelli, M., MRI characterization of myocardial tissue in patients with Fabry’s disease (2007) AJR Am J Roentgenol, 188, pp. 850-853. , PID: 17312078
Imbriaco, M., Messalli, G., Avitabile, G., Cuocolo, A., Maurea, S., Soscia, F., Cardiac magnetic resonance imaging illustrating Anderson-Fabry disease progression (2010) Br J Radiol, 83, pp. 249-251. , COI: 1:STN:280:DC%2BC3cbotVagtQ%3D%3D, PID: 21088081
White, J.A., Rajchl, M., Butler, J., Thompson, R.T., Prato, F.S., Wisenberg, G., Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography–magnetic resonance imaging for the diagnosis of cardiac disease (2013) Circulation, 127, pp. 639-641. , PID: 23733970
First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(498 views) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 ViewExport to BibTeXExport to EndNote
Malvindi MA, Greco A, Conversano F, Figuerola A, Corti M, Bonora M, Lascialfari A, Doumari HA, Moscardini M, Cingolani R, Gigli G, Casciaro S, Pellegrino T, Ragusa A * MR Contrast Agents(292 views) Small Animal Imaging, 2011 Jul 8; 21(13): 2548-2555. Impact Factor:1.784 ViewExport to BibTeXExport to EndNote
Ntziachristos V, Cuénod CA, Fournier L, Balvay D, Pradel C, Siauve N, Clement O, Jouannot E, Lucidarme O, Vecchio SD, Salvatore M, Law B, Tung C-H, Jain RK, Fukumura D, Munn LL, Brown EB, Schellenberger E, Montet X, Weissleder R, Clerck ND, Postnov A * Tumor Imaging(350 views) Textbook Of In Vivo Imaging In Vertebrates (ISSN: 9780-4700), 2007 Jul 16; 1: 277-309. Impact Factor:1.148 ViewExport to BibTeXExport to EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(731 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote